Question Bank › Nobody is coming: management describes a market

Nobody is coming: management describes a market it must build itself, and the first buyers have started paying

Calls Tested
466
Answered YES
8
Hit Rate
1.7%
rare by design

DHI Group, Inc. (DHX) — this company's answers

NO on the Q2 2017 call 2017-07-28 D
The model's full reasoning — Q2 2017 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司正在创造一个新市场,即主要障碍不是竞争或价格,而是需要教育、转化、改变买家习惯,并且这种转化工作已经开始成功,有实际付费买家。 分析内容: - 管理层提到“Open Web First”销售方法,推动社交招聘工具的渗透,客户数量增长,超过三分之一的Dice年客户是Open Web客户。这似乎是在推广新产品,但这是否是市场创造?Open Web是Dice的一个产品,客户采用它可能是在改变招聘方式,但这是否是“创造市场”? - 管理层提到“getTalent”和“Lengo”等产品,但getTalent采用率“spotty”,未达预期,而Lengo在英国的采用率不错,但仍在推广中。 - 管理层提到“Google for Jobs”合作,但这是外部平台。 - 关键点:管理层是否说主要障碍是买家需要被教育、改变习惯?在回答中,Mike提到“我们正在解决客户痛点”,但并没有明确说买家需要被教导或改变习惯。相反,他们提到竞争激烈,客户对ROI的看法影响业务。 - 关于“市场创造”的表述:管理层提到“我们正在扩大营销努力”,但这是品牌推广,不是教育市场。 - 在回答分析师问题时,Mike提到“宏观环境对技术专业人士有利”,但未提及需要改变买家行为。 - 管理层提到“Open Web”的采用率增长,但这是产品采用,不是市场创造。客户可能从其他方式转向Open Web,但这是竞争性产品,不是全新市场。 - 没有明确说“买家必须改变习惯”或“我们正在教育市场”。相反,他们提到“竞争”和“客户ROI感知”作为挑战。 - 关于“转化工作开始成功”:有提到Open Web客户增长,但这是产品采用,不是市场创造。而且getTalent未达预期。 因此,管理层没有描述一个需要创造市场的场景,而是描述了一个竞争激烈的市场,他们正在推出新产品以争夺份额。没有提到买家需要被教育或改变习惯作为主要障碍。所以答案应为NO。 最终答案:NO

← Back to the full DHX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe the company as CREATING A MARKET THAT DOES NOT YET PROPERLY EXIST — that is, does management convey that the main obstacle in front of the business is not competition or price but the fact that the buyers themselves must first be TAUGHT, CONVERTED, QUALIFIED, OR HAVE THEIR OWN HABITS AND SYSTEMS CHANGED before they can buy at all — AND does management report that this conversion work has now begun to succeed with real paying buyers in the recent period? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent situation with both halves present as a present-tense reality: (1) THE COMPANY IS DOING MARKET-CREATION WORK, NOT MARKET-SHARE WORK. Management describes effort spent on getting the world ready to buy, rather than on beating rivals for demand that already exists. Any genuine expression of this counts, and the form varies widely across industries — for example: management explaining that customers must be educated on a category, method, material, or approach they do not yet understand or trust; that buyers have to change an entrenched practice, workflow, standard, specification, protocol, or supply arrangement in order to adopt; that the company is spending its time training, certifying, demonstrating, running side-by-side comparisons, or working through customers' internal validation, testing, trial, or approval processes; that adoption is slow because decision-makers have never bought anything like this and there is no existing budget line, reimbursement path, permitting route, or procurement category for it; that the company is having to build the surrounding conditions of its own market — installers, prescribers, applicators, inspectors, dealers, code acceptance, industry awareness, or downstream capability — before volume can flow; or that the company's chief competitor is inertia, the status quo, or "the way it has always been done" rather than another vendor. Management should convey that this conversion problem, rather than winning a competitive bid, is what actually governs how fast the business grows. (2) THE CONVERSION IS NOW ACTUALLY WORKING, WITH MONEY BEHIND IT. Management points to concrete evidence from the recent period that the resistance is giving way and buyers are crossing over: converts who have moved from the old way to the company's way and are now purchasing; customers who completed their evaluation, testing, or internal approval and have begun ordering; adoption spreading from the earliest believers to more conventional or larger buyers; practices, specifications, or standards beginning to be written the company's way; or the pace of conversions picking up relative to what the company used to achieve. The evidence must be present-tense and paid — real orders, customers, deployments, or usage happening now — not merely interest, education efforts underway, or a large market management believes exists. The essence is ONE phenomenon: a company whose growth is gated by how fast it can change other people's minds and habits, which has just started to win that argument at scale. The industry, the entrenched habit being displaced, and the form of the conversion may vary widely. Answer NO if the company competes for demand that plainly already exists — bidding, winning share, out-selling rivals, or serving an established buying pattern — however well it is doing. NO if management merely asserts a large addressable market, a superior product, or that customers "just need to see it," without describing an adoption barrier of habit, understanding, qualification, or established practice that must be overcome first. NO if the education, trialing, or qualification work is described with nothing yet converting into paying business — pilots without orders, interest without commitment, a market being "developed" with no crossings to point to. NO if the conversion described is chiefly the company's own customers upgrading to its newer product generation rather than outsiders changing their existing practice. NO if the barrier described is purely a pending external approval or a single regulatory gate with no buyer-behavior change involved. NO if management is chiefly explaining that adoption has stalled, slowed, or proven harder than expected with no recent progress. NO if the idea appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CALX Calix, Inc. Q1 2023 2023-04-20 C+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
HLNE Hamilton Lane Incorporated Q1 2023 2022-08-02 C+
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
ALKS Alkermes plc Q3 2018 2018-10-23 C
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
PCRX Pacira BioSciences, Inc. Q4 2017 2018-02-28 C

How the model reasoned

ILMN · Q1 2018 → YESThe question is whether management describes the company as creating a market that doesn't yet properly exist, where the main obstacle is teaching/converting buyers, changing their habits, and that th...YES The transcript shows management framing Illumina's growth as market creation in the "earliest stages of the genomics journey," where the core obstacle is buyer education, habit change, and qualification rather than competing for existing demand. They describe heavy investment in studies (Harvard Pilgrim NIPT, MiSeq rugged, UK Biobank, 100k Genomes) to generate clinical/economic evidence for payers and physicians, regulatory progress (CMS NCD, FDA 23andMe BRCA approval), and expanding reimbursement paths. This is explicitly positioned as overcoming inertia and entrenched practices ("the way it has always been done") before volume flows.
EXFY · Q2 2022 → YESThe question is whether management describes the company as creating a market that doesn't yet properly exist, with both market-creation work and successful conversion with paying buyers. YES The transcript shows David Barrett describing the SMB expense-management market as "largely untouched" with "hundreds of millions of businesses" where "virtually none of them do anything," positioning Expensify as the first to introduce concepts like real-time expense scanning and pre-accounting through ExpensiCon to educate and change accounting-industry habits. This frames the core obstacle as buyer conversion and habit change rather than direct rivalry. He contrasts this with competitors retreating to enterprise sales due to defaults and cost pressures, while Expensify's bottom-up model and Free Plan enable early-stage onboarding.
SGRY · Q2 2022 → YESThe question is whether management describes the company as creating a market that doesn't yet properly exist, where the main obstacle is teaching/converting buyers, changing their habits, and that th...YES The transcript shows management framing the core growth driver as a site-of-care shift that requires buyers (physicians, payers, patients) to change entrenched habits and systems: physicians must be recruited and trained to perform procedures in ASCs rather than hospitals; payers must adopt value-based incentives and capitated models to move volume 5-figure discounts; patients must accept lower-cost, high-quality outpatient settings. This is presented as the primary obstacle to faster growth, not competitive bidding for already-existing demand.

More from the question bank

Insulated through the downturnThe bridge is already builtManagement volunteers specific, checkable nuScarcity of the company's own outputThe company is being paid to solve a problemBet-the-company financing already spent on hAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.